Objectives: Primary Objective: The primary objective is to identify the difference in the estimation of prognosis of advanced cancer patients between medical oncologists, gynecological oncologists, and palliative care physicians
Full Title of Study: “What is the Difference in the Estimation of Prognosis of Advanced Cancer Patients Between Medical Oncologist, Gynecological Oncologists, and Palliative Care Physicians?”
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: December 2030
The goal of this research study is to identify the difference in the estimation of prognosis of advanced cancer patients between medical or gynecological oncologists, and palliative care physicians. Up to 140 patients will be enrolled in this study.
- Behavioral: Estimation of Prognosis Questionnaire
- Survey will examine two aspects of prognosis estimation: 1.) physician factors, 2.) prognosis estimation and contributing factors to patient prognosis. Survey will take approximately 5 minutes to complete.
Arms, Groups and Cohorts
- Medical Oncology Physicians
- Medical oncology physicians are sent the Estimation of Prognosis questionnaire by email.
- Palliative Care Physicians
- Palliative care physicians are sent the Estimation of Prognosis questionnaire by email.
Clinical Trial Outcome Measures
- Estimation of Patient Overall Survival by Oncologists and by Palliative Care Physicians per Estimation of Prognosis Questionnaire
- Time Frame: 6 weeks
- The answer to the question #4, “How long do you think this patient will live?” in the questionnaire is the primary endpoint. Denoting the oncologist estimated OS time from the day of palliative care consult to death by TOnc, palliative care physician estimate by TPalliative, and the true OS time by T0, we define the accuracy of the estimation of OS by oncologists and by palliative care physician as ΔOnc = TOnc – T0 ΔPalliative = TPalliative – T0. And the difference between these two estimates is calculated as ΔOS = ΔOnc – ΔPalliative. Based on the above formulas, ΔOS is actually calculated as (TOnc- TPalliative). The true survival time, T0, is cancelled out by the subtraction.
Participating in This Clinical Trial
1. Medical oncologists or gynecological who referred patients to the palliative care team; Palliative Care physicians to whom the patients were referred; Patients with locally advanced, metastatic, or, not curable cancer. 2. 18 years old or older Exclusion Criteria:
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- M.D. Anderson Cancer Center
- Provider of Information About this Clinical Study
- Overall Official(s)
- Angelique N. Wong, MD, Principal Investigator, M.D. Anderson Cancer Center
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.